← World Journal of Gastrointestinal Pharmacology and Therapeutics

Papers in World Journal of Gastrointestinal Pharmacology and Therapeutics

Page 5 · newest first

201. Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient managementWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2015
202. Role of peroxisome proliferator-activated receptors alpha and gamma in gastric ulcer: An overview of experimental evidencesWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2015
203. Present state and future challenges in pediatric abdominal pain therapeutics research: Looking beyond the forestWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2015
204. Pharmacotherapy for the management of achalasia: Current status, challenges and future directionsWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2015
205. Current position of vasoconstrictor and albumin infusion for type 1 hepatorenal syndromeWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2015
206. Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?World Journal of Gastrointestinal Pharmacology and Therapeutics · 2015
207. Nociceptin effect on intestinal motility depends on opioid-receptor like-1 receptors and nitric oxide synthase co-localizationWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2015
208. Pharmaceutical management of hepatitis B and C in liver and kidney transplant recipientsWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2015
209. Inflammatory bowel disease: Traditional knowledge holds the seeds for the futureWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2015
210. Age-related differences in celiac disease: Specific characteristics of adult presentationWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2015
211. Typical and atypical symptoms of gastro esophageal reflux disease: DoesHelicobacter pyloriinfection matter?World Journal of Gastrointestinal Pharmacology and Therapeutics · 2015
212. Pharmacological therapy of feed intolerance in the critically illsWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2014
213. Endoscopic ultrasonography: Challenges and opportunities in the developing worldWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2014
214. Use of thiopurines in inflammatory bowel disease: Safety issuesWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2014
215. Colonoscopy preparation-induced disorders in renal function and electrolytesWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2014
216. Aspirin, cyclooxygenase inhibition and colorectal cancerWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2014
217. Role of chemoprophylaxis with either NSAIDs or statins in patients with Barrett’s esophagusWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2014
218. Diagnosis and treatment of gastroesophageal reflux diseaseWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2014
219. Histamine₂-receptor antagonists: Rapid development of tachyphylaxis with repeat dosingWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2014
220. Visceral hypersensitivity and electromechanical dysfunction as therapeutic targets in pediatric functional dyspepsiaWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2014
221. Ischemic heart disease, factor predisposing to Barrett’s adenocarcinoma: A case control studyWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2014
222. Prevention of hepatocellular carcinoma in patients with chronic hepatitis BWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2014
223. Statins and their role in acute pancreatitis: Case report and literature reviewWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2014
224. Clinical update for the diagnosis and treatment ofClostridium difficileinfectionWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2014
225. Inflammatory bowel diseases: Current problems and future tasksWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2014
226. Approach toHelicobacter pyloriinfection in geriatric populationWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2014
227. Esophageal motility abnormalities in gastroesophageal reflux diseaseWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2014
228. Use of methotrexate in inflammatory bowel disease in 2014: A User’s GuideWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2014
229. Understanding and treating refractory constipationWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2014
230. Renal dysfunction in patients with cirrhosis: Where do we stand?World Journal of Gastrointestinal Pharmacology and Therapeutics · 2014
231. Protein kinases are potential targets to treat inflammatory bowel diseaseWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2014
232. Metabolomics as a diagnostic tool in gastroenterologyWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2013
233. Steroid ulcers: Any news?World Journal of Gastrointestinal Pharmacology and Therapeutics · 2013
234. Emerging causes of iron deficiency anemia refractory to oral iron supplementationWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2013
235. Inflammatory bowel disease: An archetype disorder of outer environment sensor systemsWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2013
236. Outcome of patients with primary sclerosing cholangitis and ulcerative colitis undergoing colectomyWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2013
237. Standard triple versus levofloxacin based regimen for eradication ofHelicobacter pyloriWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2013
238. Non-dietary forms of treatment for adult celiac diseaseWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2013
239. Interaction of insulin with prokinetic drugs in STZ-induced diabetic miceWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2013
240. Reduced esophageal cancer incidence in statin users, particularly with cyclo-oxygenase inhibitionWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2013
241. Management practices of hepatitis C virus infected alcoholic hepatitis patients: A survey of physiciansWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2013
242. Validation of methods to assess potential biomarkers in pediatric patients with esophageal eosinophiliaWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2013
243. Eosinophils and mast cells as therapeutic targets in pediatric functional dyspepsiaWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2013
244. Inhibition of apoptosis in the management of nonalcoholic fatty liver diseaseWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2013
245. Lactose malabsorption and intolerance: What should be the best clinical management?World Journal of Gastrointestinal Pharmacology and Therapeutics · 2012
246. Therapy of gallstone disease: What it was, what it is, what it will beWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2012
247. Non-bismuth quadruple therapy for first-line Helicobacter pylori eradication: A randomized study in JapanWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2012
248. Helicobacter pyloritherapy: Present and futureWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2012
249. Is concomitant quadruple therapy for Helicobacter pylori eradication really needed for Japanese patients?World Journal of Gastrointestinal Pharmacology and Therapeutics · 2012
250. Prevention of hepatitis C recurrence after liver transplantation: An updateWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2012